Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01630434 · ClinicalTrials.gov registry record · NA
International Randomized Study of the TransMedics Organ Care System (OCS Lung) for Lung Preservation and Transplantation
A NA study, sponsored by TransMedics.
- Completed
- Registry status
- NA
- Development phase
- 320
- Enrollment target
NCT01630434 is a NA study that has completed, run by TransMedics. The registered enrollment target is 320 participants.
The verdict
NCT01630434, a NA study, has completed, sponsored by TransMedics.
- COMPLETED
- Registry status
- NA
- Development phase
- 320 participants
- Enrollment target
Study Summary
A prospective, international, multi-center, randomized controlled trial comparing preservation of donor lungs using OCS-Lung perfusion device (Treatment Group) to cold flush and storage (Control Group).
Interventions
- DEVICE OCS Lung
- DEVICE Cold flush and storage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320 participants |
| Start Date | 2011-11 |
| Est. Completion | 2016-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01630434
The ClinicalTrials.gov registry entry for NCT01630434 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 320 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is TransMedics, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which OCS Lung is the first listed.
NCT01630434 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01630434 about?
NCT01630434 is a clinical study titled "International Randomized Study of the TransMedics Organ Care System (OCS Lung) for Lung Preservation and Transplantation". A prospective, international, multi-center, randomized controlled trial comparing preservation of donor lungs using OCS-Lung perfusion device (Treatment Group) to cold flush and storage (Control Group).
What is the current status of trial NCT01630434?
This trial is currently completed. It is a NA study. The enrollment target is 320 participants. The study started on 2011-11. Estimated completion is 2016-04.
What interventions are being tested in trial NCT01630434?
The interventions under investigation include: OCS Lung (DEVICE), Cold flush and storage (DEVICE).
Who is sponsoring clinical trial NCT01630434?
This trial is sponsored by TransMedics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.